€4.15
3.75%
Xetra, Apr 25, 05:36 pm CET
ISIN
DE000A2E4T77
Symbol
2HRA
Index
Industry

H&R GmbH & Co KgaA Stock price

€4.15
-0.15 3.49% 1M
+0.44 11.86% 6M
+0.76 22.42% YTD
-0.58 12.26% 1Y
-1.89 31.29% 3Y
+0.20 5.06% 5Y
-3.55 46.13% 10Y
Xetra, Closing price Fri, Apr 25 2025
+0.15 3.75%
ISIN
DE000A2E4T77
Symbol
2HRA
Index
Industry

Key metrics

Market capitalization €154.47m
Enterprise Value €328.26m
P/E (TTM) P/E ratio 14.54
EV/FCF (TTM) EV/FCF 17.67
EV/Sales (TTM) EV/Sales 0.25
P/S ratio (TTM) P/S ratio 0.12
P/B ratio (TTM) P/B ratio 0.36
Dividend yield 2.41%
Last dividend (FY25) €0.10
Revenue growth (TTM) Revenue growth -1.04%
Revenue (TTM) Revenue €1.34b
EBIT (operating result TTM) EBIT €32.19m
Free Cash Flow (TTM) Free Cash Flow €18.58m
Cash position €62.53m
EPS (TTM) EPS €0.29
P/E forward 11.53
P/S forward 0.11
EV/Sales forward 0.24
Show more

Is H&R GmbH & Co KgaA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

H&R GmbH & Co KgaA Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a H&R GmbH & Co KgaA forecast:

1x Buy
50%
1x Sell
50%

Analyst Opinions

2 Analysts have issued a H&R GmbH & Co KgaA forecast:

Buy
50%
Sell
50%

Financial data from H&R GmbH & Co KgaA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,338 1,338
1% 1%
100%
- Direct Costs 1,192 1,192
2% 2%
89%
147 147
7% 7%
11%
- Selling and Administrative Expenses 52 52
18% 18%
4%
- Research and Development Expense - -
-
-
95 95
2% 2%
7%
- Depreciation and Amortization 63 63
1% 1%
5%
EBIT (Operating Income) EBIT 32 32
5% 5%
2%
Net Profit 11 11
1% 1%
1%

In millions EUR.

Don't miss a Thing! We will send you all news about H&R GmbH & Co KgaA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. It operates through the following segments: ChemPharm Refining, ChemPharm Sales, Plastics, and Other Activities. The ChemPharm Refining segment includes paraffins, white oils, plasticizers, base oils, lubricants, and other crude-oil-based specialty products. The ChemPharm Sales segment encompasses foreign firms that process chemical pharmaceutical raw materials and distribute it as new products. The Plastic segment develops, manufactures, and sells high-precision plastic parts produced using the injection-molding method. The Other Activities segment includes activities associated with non-operating companies. The company was founded in 2001 and is headquartered in Salzbergen, Germany.

Head office Germany
CEO Niels Hansen
Employees 1,705
Founded 1919
Website www.hur.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today